Dr. Scott J. Samuelson, M.D.
Medical Oncology (Medical Oncology Physician)
389 S 900 E, Ste 100
Salt Lake City, UT 84102
Who else practices at this address →
Salt Lake County includes primary care (36% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 24
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 278
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
UT license 5918534-1205 -
Hematology & Oncology Physician
UT license 5918534-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Intermountain Medical Center Murray, UT
- Intermountain Health Riverton Hospital Riverton, UT
- Lds Hospital Salt Lake City, UT
- Intermountain Health Alta View Hospital Sandy, UT
- St Mark's Hospital Salt Lake City, UT
Medical groups
- Utah Cancer Specialists PC (49 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 278
- Services billed
- 80,480
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, aprepitant, 1 mg | 6,240 | 18 |
| Injection, granisetron, extended-release, 0.1 mg | 3,100 | 11 |
| Injection, dexamethasone sodium phosphate, 1 mg | 1,600 | 36 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 756 | 224 |
| Blood test, comprehensive group of blood chemicals | 668 | 207 |
| Established patient office or other outpatient visit, 30-39 minutes | 398 | 140 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 385 | 11 |
| Injection, magnesium sulfate, per 500 mg | 320 | 11 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 271 | 42 |
| Established patient office or other outpatient visit, 20-29 minutes | 202 | 134 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in Salt Lake City, UT | 151 |
| Abiraterone Acetate | 129 |
| Imbruvica (ibrutinib) | 37 |
| Prochlorperazine Maleate Other prescribers in Salt Lake City, UT | 35 |
| Hydroxyurea Other prescribers in Salt Lake City, UT | 33 |
| Xtandi (enzalutamide) | 28 |
| Venclexta (venetoclax) | 24 |
| Cabometyx (cabozantinib s-malate) | 24 |
| Levofloxacin Other prescribers in Salt Lake City, UT | 21 |
| Dexamethasone Other prescribers in Salt Lake City, UT | 20 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 28 payments worth $553 in total to this clinician.
| Pfizer Inc. | $183 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $78.35 |
| Array Biopharma Inc | $61.06 |
| Bayer HealthCare Pharmaceuticals Inc. | $57.63 |
| EMD Serono, Inc. | $36.05 |
| Genmab U.S., Inc. | $30.49 |
| Daiichi Sankyo Inc. | $29.00 |
| AbbVie Inc. | $22.28 |
| Food and Beverage | $553 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.